Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
The Oncologist|March 8, 2008
Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directionsSuresh Ramalingam, Chandra BelaniFuture Oncology (London, England)|March 27, 2007
Role of bevacizumab for the treatment of non-small-cell lung cancerSuresh Ramalingam, Chandra P BelaniExpert Opinion on Therapeutic Targets|January 18, 2007
Recent advances in targeted therapy for non-small cell lung cancerSuresh Ramalingam, Chandra P BelaniJournal of the National Comprehensive Cancer Network : JNCCN|April 2, 2008
Small cell lung cancer in elderly patients: a reviewTaofeek K Owonikoko, Suresh RamalingamThe Oncologist|June 24, 2006
Salvage therapy for advanced non-small cell lung cancer: factors influencing treatment selectionSuresh Ramalingam, Alan B SandlerCurrent Treatment Options in Oncology|November 11, 2008
The role of targeted agents in the treatment of elderly patients with non-small cell lung cancer (NSCLC)Taofeek K Owonikoko, Suresh RamalingamExpert Opinion on Pharmacotherapy|December 1, 2005
Molecularly-targeted therapies for non-small cell lung cancerSuresh Ramalingam, Chandra P BelaniLung Cancer (Amsterdam, Netherlands)|April 29, 2008
Gene expression profiling of non-small cell lung cancerSunil Singhal, Daniel Miller, Suresh Ramalingam, et al.Oncology (Williston Park, N.Y.)|June 7, 2008
Management of a patient with stage IIIA (N2) NSCLCKathryn Carlson, B Zach Fowler, Daniel L Miller, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 27, 2006
A liquid chromatography-electrospray ionization tandem mass spectrometric assay for quantitation of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamicacid, SAHA), and its metabolites in human serumRobert A Parise, Julianne L Holleran, Jan H Beumer, et al.Pageof 7